ScRNAseq of BRAF-mutant Colo205 cells control or treated for 24h or 72h with vemurafenib

ABSTRACT: The experiment investigates transcriptional response of BRAF-mut Colo205 cancer cells following treatment for 24h or 72h with BRAF-inhibitor vemurafenib compared to control cells on a single cell level.

INSTRUMENT(S): Illumina NovaSeq 6000

ORGANISM(S): Homo sapiens

SUBMITTER: Johannes Braegelmann 

PROVIDER: E-MTAB-9890 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress